# Jim Plante

> Jim Plante is an electrical engineer turned repeat founder whose career has moved from millimeter-wave radios and fleet telematics to genetic testing, biotechnology investing, and healthcare-market infrastructure. He is the founder and chairman of Klotho Therapeutics, managing partner of Thynk Capital, and co-founder and CEO of IMX, where his recurring playbook is to take a technically dense problem, assemble specialists around it, and turn it into a product or market people can use.

- **Role:** Co-founder and CEO at IMX; founder, chairman, and CEO at Klotho Therapeutics; managing partner at Thynk Capital
- **Organizations:** IMX, IMX Data, Klotho Therapeutics, Thynk Capital, Foundation for Kidney Transplant Research, Pathway Genomics, SmartDrive Systems, E-Band Communications, Bel-Tronics
- **Education:** Bachelor's degree in electrical engineering, Southern Illinois University
- **Known for:** Founded or co-founded companies across wireless communications, commercial fleet safety, genetic testing, biotechnology, investment, and financial-market infrastructure., Helped E-Band Communications commercialize radio systems in the 71-76 GHz and 81-86 GHz spectrum bands., Built SmartDrive around integrated video, audio, GPS, and sensor data for commercial-fleet safety and coaching.

## Career timeline

- **1996-1997** — Served as president of Bel-Tronics.
- **2002-2004** — Co-founded and led E-Band Communications, working to commercialize millimeter-wave radio technology.
- **2004-2008** — Founded and served as CEO and chairman of SmartDrive Systems, a video and sensor-based fleet-safety business.
- **2008-2017** — Founded and led Pathway Genomics, a San Diego genetic-testing company.
- **2011** — Founded Thynk Capital to invest in early-stage technology, healthcare, and life-science companies.
- **2014** — Founded the Foundation for Kidney Transplant Research as a public-policy and education initiative.
- **2015-2018** — Served on a U.S. Industry Trade Advisory Committee for chemicals, pharmaceuticals, health, and science products.
- **2017** — Founded Klotho Therapeutics and announced a $10 million Series A financing round.
- **2021** — Co-founded and became CEO of Intelligent Medicine Exchange, known as IMX.
- **2024** — IMX Health received CFTC designation as a contract market; its Morningstar U.S. Healthcare Index Futures product was subsequently certified.
- **2024** — IMX won the FIA Expo Innovators Pavilion People's Choice award.
- **2025** — IMX Data reported achieving SOC 2 Type II certification.

## Achievements

- Founded or co-founded companies across wireless communications, commercial fleet safety, genetic testing, biotechnology, investment, and financial-market infrastructure.
- Helped E-Band Communications commercialize radio systems in the 71-76 GHz and 81-86 GHz spectrum bands.
- Built SmartDrive around integrated video, audio, GPS, and sensor data for commercial-fleet safety and coaching.
- Raised more than $130 million in reported funding for Pathway Genomics by early 2016, including a $40 million Series E round.
- Served on a U.S. Industry Trade Advisory Committee from 2015 to early 2018.
- Is listed as a co-inventor on patent filings concerning products and methods for assessing and increasing Klotho protein levels.
- Led IMX through CFTC designation as a contract market in January 2024.
- Led IMX when it won the FIA Expo Innovators Pavilion People's Choice award in 2024.

## Latest updates

- **2025** — IMX Data reported that it achieved SOC 2 Type II certification and continued developing healthcare-claims data products for financial institutions.
- **2024-11** — IMX was voted the FIA Expo Innovators Pavilion People's Choice winner.
- **2024-11** — An Australian divisional patent application naming James R. Plante and colleagues as inventors was published for products and methods related to Klotho protein levels.
- **2024-01** — The CFTC designated IMX Health as a contract market and certified its Morningstar U.S. Healthcare Index Futures product later that month.

## Links

- Website: https://www.klotho.com/
- LinkedIn: https://www.linkedin.com/in/jimplante
- Twitter/X: https://twitter.com/jimplante
- Facebook: https://www.facebook.com/klothotherapeutics/

---

Profile page: https://yespress.io/jim-plante
Published by YesPress — https://yespress.io
Last updated: 2026-08-25